I am thrilled and honoured to share that I have been conferred the Alumni Medalist Award 2024 by The Ohio State University Alumni Association. My heartfelt gratitude to The Ohio State University alumni community for this prestigious award, and to my mentors and colleagues for the incredible support throughout my journey.
As a co-founder of the Foundation for Neglected Disease Research, the last 10 years have been incredibly fulfilling, with active contributions to the global drug pipeline for infectious and neglected tropical diseases. FNDR was started with the mission to save lives lost due to infectious diseases, and we fulfil our mission through drug discovery and development programs across multiple indications. FNDR’s clinical candidate for the treatment of tuberculosis, TBA-7371, which is being developed in collaboration with Bill & Melinda Gates Medical Research Institute and TB Alliance, has successfully completed the Phase 2A clinical trial in TB patients with the results underscoring its potential in the treatment of TB.
As a co-founder of Peptris Technologies, where we use AI/ML to help discover new drugs or repurpose existing drugs for devastating rare diseases with high unmet medical need like Duchenne Muscular Dystrophy. We hope to have our first clinical candidate for DMD in next 8-12 months.
With the ultimate goal of serving humanity, I look forward to the future and the many ways in which we can tackle global health challenges with innovative, affordable, and accessible solutions, and promote health equity across the globe.
https://lnkd.in/gQgQzkCD
#OSU Alumni Association #Foundation for Neglected Disease Research #CCAMP #Peptris #Ohio State University College of Pharmacy